Abiopharma

🔍 Ganesh Balakrishnan A (Executive)

Company: Frontdoor, Inc. (FTDR)

Report Date: 2026-03-30

Detailed Transactions and Holdings:

• Acquired 13,982 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-30 | Code: A | equity_swap_involved: false | shares_owned_after: 13,982.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Reflects restricted stock units that upon vesting convert into shares of common stock on a one-for-one basis.
• F2: Each unit is the economic equivalent of one share of the Company's stock. The restricted stock units were granted on March 30, 2026 and will vest and settle in three equal installments on March 30, 2027, 2028 and 2029, subject to continued service with the Company.